AMAG Pharmaceuticals Rövid arány
Mi az AMAG Pharmaceuticals Rövid arány?
A Rövid arány az AMAG Pharmaceuticals, Inc. - 1.83
Mi a Rövid arány meghatározása?
A rövid arány az értékesített részvények rövid száma, az átlagos napi mennyiséggel elosztva.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Rövid arány a Health Care szektor a NASDAQ-on cégekben a AMAG Pharmaceuticals -hoz képest
Mit csinál AMAG Pharmaceuticals?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
rövid arány -hoz hasonló cégek AMAG Pharmaceuticals
- CDK Global Inc nak Rövid arány 1.82 van
- Altria nak Rövid arány 1.82 van
- Brasilagro Companhia Brasileira De Propriedade Agricola nak Rövid arány 1.82 van
- BlackRock TCP Capital Corp nak Rövid arány 1.82 van
- TORM plc nak Rövid arány 1.82 van
- H&R Real Estate Investment Trust nak Rövid arány 1.82 van
- AMAG Pharmaceuticals nak Rövid arány 1.83 van
- Elysee Development nak Rövid arány 1.84 van
- In8 Bio nak Rövid arány 1.84 van
- Graybug Vision nak Rövid arány 1.84 van
- Western Asset Investment Grade Income Fund Inc nak Rövid arány 1.84 van
- Fortinet Inc nak Rövid arány 1.84 van
- National nak Rövid arány 1.84 van